How do you help a start-up biotech secure financing and attract development partners? SmithSolve created corporate branding tools and a targeted media strategy to elevate ENDECE, an emerging leader in the fight against severe neurological diseases. By focusing on the company’s science, SmithSolve increased awareness of the clinical and commercial potential value of the company’s lead compound for MS, setting the stage for clinical trials.

Assignment

  • As a small, relatively unknown biotech company, ENDECE faced the significant challenge of generating interest in a novel strategy for treating multiple sclerosis. To advance the compound into clinical trials, ENDECE needed to introduce strong science and impressive pre-clinical data while simultaneously elevating its corporate reputation. Increase visibility of ENDECE Neural among potential partners and investors
  • Share the breakthrough science behind the company’s lead compound
  • Assess patient willingness to participate in potential clinical trials

Slved

Solved

Our work included:

  • Developed core materials to guide all communications, including messages, Q&A, master narrative, elevator speech, corporate fact sheet, newsletter
  • Created new corporate website aligned with corporate branding
  • Developed news announcements for data presentation, publication, research grants
  • Created MS patient survey to confirm interest in potential clinical trials

Results

  • Generated original coverage in 10+ biotech and MS-related publications
  • Arranged 8+ meetings with leading biotech and pharmaceutical companies
  • Secured 2 company profiles in influential media outlets
  • Garnered 1,100 responses to a 4-week patient survey
  • Developed 6 new corporate branding assets

“SmithSolve raised our profile and sparked interest in our science. They move with speed, skill and accuracy.”

James Yarger, Ph.D.
CEO
ENDECE Neural